Form 13-F position report Filing season in progress

TEVA PHARM IND LTD SHS 1 UT RE

Reported by Yelin Lapidot Holdings Management Ltd

TEVA CUSIP M8769Q102 Manager CIK 0001590495

First reported at 242,649 shares this quarter.

New
% of reported 13F value 1.75% This manager · Q3 2026
Shares 242,649 Quarter-end amount reported
Reported value $9,608,900 Fair value at quarter end
Consecutive quarters held 1 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-09-30 9608900

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for TEVA PHARM IND LTD SHS 1 UT RE held by Yelin Lapidot Holdings Management Ltd.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 New 242,649 +242,649 (0.0%) 1.75% $9,608,900 2026-10-26

Who else reported the position

194 managers reported TEVA PHARM IND LTD SHS 1 UT RE for Q3 2026 so far.

Managers reporting TEVA PHARM IND LTD SHS 1 UT RE in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Harel Insurance Investments & Financial Services Ltd New 34,655,415 +34,655,415 6.45% $1,372,354,000 1 qtr
Exor Capital LLP New 17,534,745 +17,534,745 12.1% $694,375,902 1 qtr
Y D More Investments Ltd New 6,923,285 +6,923,285 7.99% $277,374,853 1 qtr
TODD ASSET MANAGEMENT LLC New 3,502,189 +3,502,189 2.52% $138,883,103 1 qtr
DIMENSIONAL FUND ADVISORS LP New 3,154,123 +3,154,123 0.02% $124,908,833 1 qtr
Citigroup Inc New 2,506,076 +2,506,076 0.03% $100,342,486 1 qtr
SEB Asset Management AB New 1,669,386 +1,669,386 0.24% $66,107,596 1 qtr
Assenagon Asset Management S A New 1,382,784 +1,382,784 0.05% $55,352,174 1 qtr
MACKENZIE FINANCIAL CORP New 1,214,561 +1,214,561 0.05% $48,131,760 1 qtr
Sumitomo Mitsui Trust Holdings Inc New 769,408 +769,408 0.02% $30,468,557 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
October 26, 2026
Filing type
13F-HR
Position type
SHS

Voting authority reported

Sole
242,649
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.